4//SEC Filing
MERRIMACK PHARMACEUTICALS INC 4
Accession 0001209191-17-032046
CIK 0001274792operating
Filed
May 11, 8:00 PM ET
Accepted
May 12, 5:00 PM ET
Size
8.8 KB
Accession
0001209191-17-032046
Insider Transaction Report
Form 4
Drummond Daryl C
Head of Research
Transactions
- Exercise/Conversion
Common Stock
2017-05-12$2.69/sh+4,097$11,021→ 105,828 total(indirect: By Spouse) - Exercise/Conversion
Stock Option (right to buy)
2017-05-12−4,097→ 0 total(indirect: By Spouse)Exercise: $2.69Exp: 2017-07-03→ Common Stock (4,097 underlying) - Sale
Common Stock
2017-05-12$3.72/sh−4,097$15,241→ 101,731 total(indirect: By Spouse)
Footnotes (1)
- [F1]This option is fully vested.
Documents
Issuer
MERRIMACK PHARMACEUTICALS INC
CIK 0001274792
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001274792
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 5:00 PM ET
- Size
- 8.8 KB